Known targets — ChEMBL curated mechanism
GRIA1GRIA2GRIA3GRIA4SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9A
The experimentally established mechanism targets of Irampanel. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR7 | P34969 | 2/20 | 0.62 |
| ▸ | TTR | P02766 | 1/20 | 0.57 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 9/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.55 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.53 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.53 |
| ▸ | NPC1 | O15118 | 7/20 | 0.53 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.51 |
| ▸ | RAB9A | P51151 | 7/20 | 0.51 |
| ▸ | GAA | P10253 | 1/20 | 0.51 |
| ▸ | TP53 | P04637 | 5/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.50 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.49 |
| ▸ | MEN1 | O00255 | 3/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.49 |
| ▸ | MAPT | P10636 | 3/20 | 0.49 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Irampanel SCHEMBL678128 | 0.99 | HTR7 (0.63) | HTR7TTRNPSR1SMN1; SMN2ALDH1A1 | |
| SCHEMBL7955292 | 0.90 | TTR (0.55) | HTR7TTRNPSR1SMN1; SMN2ALDH1A1 | |
| SCHEMBL7958390 | 0.90 | TTR (0.55) | HTR7TTRNPSR1SMN1; SMN2ALDH1A1 | |
| SCHEMBL5959899 | 0.90 | TTR (0.72) | HTR7TTRNPSR1SMN1; SMN2ALDH1A1 | |
| SCHEMBL7954897 | 0.90 | HTR7 (0.56) | HTR7TTRNPSR1SMN1; SMN2ALDH1A1 | |
| SCHEMBL7956790 | 0.89 | TTR (0.54) | HTR7TTRNPSR1SMN1; SMN2ALDH1A1 | |
| SCHEMBL7955222 | 0.89 | TTR (0.54) | HTR7TTRNPSR1SMN1; SMN2ALDH1A1 | |
| SCHEMBL5736080 | 0.89 | NPSR1 (0.54) | HTR7TTRNPSR1SMN1; SMN2ALDH1A1 | |
| SCHEMBL5736045 | 0.89 | HTR7 (0.63) | HTR7NPSR1SMN1; SMN2ALDH1A1KDM4E | |
| SCHEMBL7961594 | 0.88 | MAPT (0.59) | HTR7TTRNPSR1SMN1; SMN2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6797692-B1 | Use of glutamate antagonists for the treatment of cancer | IKONOMIDOU HRISSANTHI (DE) | 2004-09-28 | — | — | US | claimed |
| EP-1124553-A1 | NEW USE OF GLUTAMATE ANTAGONISTS FOR THE TREATMENT OF CANCER | Ikonomidou, Hrissanthi (DE) | 2001-08-22 | — | — | EP | claimed |
| WO-2000024395-A1 | NEW USE OF GLUTAMATE ANTAGONISTS FOR THE TREATMENT OF CANCER | IKONOMIDOU HRISSANTHI (DE) | 2000-05-04 | — | — | WO | claimed |
| EP-3955905-A1 | THERAPEUTIC COMBINATIONS, LIQUID PHARMACEUTICAL COMPOSITIONS, KITS FOR THEIR PREPARATION, AND METHODS OF THEIR USE | Prevep LLC (US) | 2022-02-23 | — | — | EP | disclosed |
| WO-2020214960-A1 | THERAPEUTIC COMBINATIONS, LIQUID PHARMACEUTICAL COMPOSITIONS, KITS FOR THEIR PREPARATION, AND METHODS OF THEIR USE | PREVEP LLC (US) | 2020-10-22 | — | — | WO | disclosed |